Robert W. Fairbairn, Director at BlackRock Science & Technology Term Trust (BSTZ), sold 18,586 shares at $22.51 ($418K) on 2025-12-18, disclosed to the SEC on 2025-12-22.
Open-market sale of $418k BSTZ by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $22.51 | 9,293 | $209K | 50.0% |
| 2 | $22.51 | 9,293 | $209K | 50.0% |
| 3 | $22.73 | 0 | $15 | 0.0% |
| Total | $22.51 avg | 18,586 | $418K | 100% |
| Filing → |
| BMEZ | SELL | 2025-12-22 | $308K | — | Filing → |
| ECAT | BUY | 2022-05-13 | $1.2M | — | Filing → |
| BSTZ | BUY | 2022-02-09 | $497K | — | Filing → |